首页> 美国卫生研究院文献>Radiation Oncology (London England) >Establishing the feasibility of the dosimetric compliance criteria of RTOG 1308: phase III randomized trial comparing overall survival after photon versus proton radiochemotherapy for inoperable stage II-IIIB NSCLC

【2h】

Establishing the feasibility of the dosimetric compliance criteria of RTOG 1308: phase III randomized trial comparing overall survival after photon versus proton radiochemotherapy for inoperable stage II-IIIB NSCLC

机译：建立RTOG 1308的剂量学依从性标准的可行性：III期随机试验比较不能进行II-IIIB期NSCLC的光子与质子放射化学疗法后的总生存期

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundTo establish the feasibility of the dosimetric compliance criteria of the RTOG 1308 trial through testing against Intensity Modulation Radiation Therapy (IMRT) and Passive Scattering Proton Therapy (PSPT) plans.

机译：背景技术通过对强度调制放射疗法（IMRT）和无源散射质子疗法（PSPT）计划进行测试，确定RTOG 1308试验的剂量学符合标准的可行性。

著录项

期刊名称 Radiation Oncology (London England)
作者
Tawfik Giaddui; Wenzhou Chen; Jialu Yu; Liyong Lin; Charles B. Simone II; Lulin Yuan; Yutao U. T. Gong; Q. Jackie Wu; Radhe Mohan; Xiaodong Zhang; Jaques B. Bluett; Michael Gillin; Kevin Moore; Elizabeth O’Meara; Jennifer Presley; Jeffrey D. Bradley; Zhongxing Liao; James Galvin; Ying Xiao;
展开▼
作者单位

展开▼
年(卷),期 2016(11),-1
年度 2016
页码 66
总页数 7
原文格式 PDF
正文语种
中图分类肿瘤学;放射医学;影像诊断学;
关键词
RTOG 1308 Dosimetric criteria IMRT Protons PSPT;

机译：RTOG 1308;剂量标准;IMRT;质子;PSPT;

相似文献

外文文献
中文文献

1. Establishing the feasibility of the dosimetric compliance criteria of RTOG 1308: phase III randomized trial comparing overall survival after photon versus proton radiochemotherapy for inoperable stage II-IIIB NSCLC [J] . Tawfik Giaddui, Wenzhou Chen, Jialu Yu, Radiation oncology . 2016,第1期

机译：建立RTOG 1308的剂量学依从性标准的可行性：III期随机试验，比较不能进行II-IIIB期NSCLC的光子与质子放射化学疗法后的总生存期
2. The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I non-small cell lung cancer (NSCLC) considered to be at higher risk of complications from surgical resection [J] . M. P. Snee, L. McParland, F. Collinson, Pilot and Feasibility Studies . 2016,第1期

机译：SABRTooth可行性试验方案：一项研究，用于确定在III期非小细胞肺癌（NSCLC）患者中进行立体定向消融放疗（SABR）与手术比较的III期随机对照试验的可行性和可接受性手术切除引起并发症的风险更高
3. Long-Term Results of RTOG 0617: A Randomized Phase 3 Comparison of Standard Dose Versus High Dose Conformal Chemoradiation Therapy plus /- Cetuximab for Stage III NSCLC [J] . Bradley J. D., Hu C., Komaki R. U., International Journal of Radiation Oncology, Biology, Physics . 2017,第2Suppla期

机译：RTOG 0617的长期结果：标准剂量的随机相3比较高剂量集合化学疗法加/ - 乙酸型阶段III NSCLC
4. A comparison of methods for estimating survival probabilities in two stage phase III randomized clinical trials. [D] . Wang, Ying. 2009

机译：在两个阶段的III期随机临床试验中比较评估生存概率的方法。
5. The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I non-small cell lung cancer (NSCLC) considered to be at higher risk of complications from surgical resection [O] . M. P. Snee, L. McParland, F. Collinson, 2016

机译：SABRTooth可行性试验方案：一项研究用于确定在III期非小细胞肺癌（NSCLC）患者中进行立体定向消融放疗（SABR）与手术比较的III期随机对照试验的可行性和可接受性手术切除并发症的风险更高
6. Establishing the feasibility of the dosimetric compliance criteria of RTOG 1308: phase III randomized trial comparing overall survival after photon versus proton radiochemotherapy for inoperable stage II-IIIB NSCLC [O] . 2016

机译：建立RTOG 1308的剂量学依从性标准的可行性：III期随机试验，比较不能进行II-IIIB期NSCLC的光子与质子放射化学疗法后的总生存期

Establishing the feasibility of the dosimetric compliance criteria of RTOG 1308: phase III randomized trial comparing overall survival after photon versus proton radiochemotherapy for inoperable stage II-IIIB NSCLC

摘要

著录项

相似文献

相关主题

期刊订阅